Fig. 6From: Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factorsDisease-free survival for the subgroup of patients with low squamous cell carcinoma level. No significant difference was found in disease-free survival between patients who did and did not receive concurrent chemotherapy (P = 0.146)Back to article page